Home » Topics » BioWorld Science

BioWorld Science
RSS

Bridge Biotherapeutics receives Korean IND clearance for BBT-176 in NSCLC

May 8, 2020

Protagonist Therapeutics reports initial phase II data on PTG-300 in polycythemia vera

May 8, 2020

Allocetra studied for COVID-19 in new phase II trial

May 8, 2020

Evelo announces IND application to study EDP-1815 for COVID-19

May 8, 2020

Ovid reports topline phase II data with OV-101 in fragile X syndrome

May 8, 2020

Positive topline data presented from phase IIa study of HTD-1801 in NASH and T2DM

May 8, 2020

New adenosine A2B receptor antagonists patented by Leadxpro

May 8, 2020

Chinese researchers identify new TLR7 agonists

May 8, 2020

FDA approves the initiation of phase II COVID-19 studies of PUL-042

May 8, 2020

Abbisko Therapeutics identifies RORC agonists

May 8, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...